Grants per year
Personal profile
Research Interests
Personalized Cancer Therapy, Precision Medicine, Early Phase Clinical Trials, First-in-Human Study, Novel Combination Cancer Therapy, Targeted therapy, Immunotherapy, Biomarker Study, Novel Drug Development, Novel Drug Delivery System, Adaptive Clinical Trials Design, Cell Signaling Pathway, Immune Checkpoint Pathway
Training Experience
| 2011 | Residency, Albert Einstein Medical Center |
| 2014 | Fellowship, University of Texas/MD Anderson Cancer Center |
Expertise related to UN Sustainable Devlopment Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
MBA, Johns Hopkins University
… → 2007
MPH, Johns Hopkins University
… → 2007
MD, Seoul National University
… → 2002
Research interests
- Oncology
Fingerprint
Dive into the research topics where Young Kwang Chae is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot #RMC-4630-02: A Phase 1b/2, Open-Label, Multicenter Dose-Escalation and Dose-Expansion Study of the Combination of RMC-4630 with Cobimetinib in Adult Participants with Relapsed/Refractory Solid Tumors and a Phase 1b Study of RMC-4630 with Osimertinib
PPD Investigator Services, LLC, Revolution Medicines, Inc.
7/7/20 → 7/7/23
Project: Research project
-
The distinct role of cysteinyl leukotriene receptor for myeloid-derived suppressive cells
Zhang, B., Chae, Y. K., Fang, D. & Sosman, J. A.
5/15/20 → 4/30/26
Project: Research project
-
A phase II basket trial of Dual Anti–CTLA–4 and Anti–PD–1 Blockade in Rare Tumors (DART) SWOG S1609: High-grade neuroendocrine neoplasm cohort
Patel, S. P., Mayerson, E., Chae, Y. K., Strosberg, J., Wang, J., Konda, B., Hayward, J., McLeod, C. M., Chen, H. X., Sharon, E., Othus, M., Ryan, C. W., Plets, M., Blanke, C. D. & Kurzrock, R., Sep 1 2021, In: Cancer. 127, 17, p. 3194-3201 8 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Blood transfusions may adversely affect survival outcomes of patients with lung cancer: A systematic review and meta-analysis
Cho, S., Park, J., Lee, M., Lee, D., Choi, H., Gim, G., Kim, L., Kang, C. Y., Oh, Y., Viveiros, P., Vagia, E., Oh, M. S., Cho, G. J., Bharat, A. & Chae, Y. K., Apr 2021, In: Translational Lung Cancer Research. 10, 4, p. 1700-1710 11 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Comparison of RECIST 1.1 and irecist in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
Park, H. J., Kim, G. H., Kim, K. W., Lee, C. W., Yoon, S., Chae, Y. K., Tirumani, S. H. & Ramaiya, N. H., Jan 1 2021, In: Cancers. 13, 1, p. 1-14 14 p., 120.Research output: Contribution to journal › Review article › peer-review
Open Access -
Definition, Incidence, and Challenges for Assessment of Hyperprogressive Disease during Cancer Treatment with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis
Park, H. J., Kim, K. W., Won, S. E., Yoon, S., Chae, Y. K., Tirumani, S. H. & Ramaiya, N. H., Mar 24 2021, In: JAMA network open. 4, 3Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
High gene expression of estrogen and progesterone receptors is associated with decreased t cell infiltration in patients with NSCLC
Oh, M. S., Anker, J. F. & Chae, Y. K., Jan 2021, In: Cancer Treatment and Research Communications. 27, 100317.Research output: Contribution to journal › Article › peer-review
Open Access